Ebola Cure Finally Discovered: Is There A Catch?
The final results of a certain clinical trial have recently suggested that the vaccine for Ebola has just been discovered. The vaccine, which was developed by Merck has been found to be the first one to show a highly effective result in preventing human infection with Ebola. Thus, health authorities say that perhaps before the end of the year, the world is set to have a wonderful Christmas gift that holds out hope for better things to come and innovations in terms of health.
The Cure For Ebola, Finally Discovered?
The vaccine, dubbed as rVSV-EBOV was considered to be the most effective to date. Among 5,837 people who received the said vaccine in the trial in Guinea in 2015, experts say that no Ebola cases were recorded 10 days or more after vaccination, which apparently signals a 100 percent protection. In one of her their statements reported by Daily Mail, World Health Organization (WHO) assistant director-general Marie-Paule Kieny, who also happens to be one of the lead researchers in the trial has claimed that if by any chance the next Ebola outbreak hits, we will not be defenseless anymore. It was found that Merck's rVSV-EBOV has already been previously used in Sierra Leone in order to contain a flare-up there.
As per Forbes, the clinical trial has allegedly involved 11,841 people who were exposed to Ebola during the last days of the West African Ebola outbreak that claimed over 11,000 lives from 2014 to 2016. Accordingly, it was found that almost half of the people who received the vaccine reported mild adverse effects, such as headache, muscle pain and fatigue, which has been reportedly cleared up after a few days; while two more people had been reported to have experienced more serious but non-fatal reactions.
Experts have further revealed that the Guinea trial took place in the coastal region of Basse-Guinée, which was still seeing new Ebola cases at the beginning of the said experiment which took place in 2015. Ultimately, it was found that GAVI, which is the global vaccine alliance, has allegedly provided $5 million earlier this year in buying 300,000 doses of rVSV-EBOV as a stockpile for future Ebola outbreaks.
Ebola Virus' New Adaptable Property Makes It More Dangerously Infectious To Humans
The upgraded mutation of the Ebola Outbreak in the areas of West Africa was found to have multiplied its infection rate when infuse to human cells.
Ebola Vaccine Passed Its First Trial
An Ebola vaccine has passed its first trial and has proved to be 100% efficient.
Ebola Vaccine Is Now 100% Effective
Results for clinical trials of Ebola vaccine was published on Dec. 22. The rVSV-ZEBOV vaccine tested with 5,837 people has 100 percent effectiveness
Ancient Maya Civilization: Newly Discovered Artificial Plateau Challenges Traditional Archaeological Beliefs
Scientists have recently discovered new information about ancient Maya civilization breaking the traditional archaeological belief.
Blind People Can Now See the Shape of Different Letters with Brain Implant
A group of scientists from the Baylor College of Medicine located in Houston has recently developed a certain brain implant that actually allows both blind and sighted participants to "see" the shape of different letters!
MORE IN ITECHPOST
Elon Musk’s Brain Microchip Neuralink Will Allegedly Cure Depression and Addiction
Elon Musk founded Neuralink in 2016, but what is the purpose of this brain-implanted computer chip? Musk has revealed additional details that you may find interesting.
Spotted in Deep Space: Never Before Seen Four Mystery Objects
A few mysterious objects that haven't been seen until now have recently been spotted in deep space thanks to massive radio telescopes.
A Leaker May Have Confirmed The Release Date Of 'Resident Evil Village'
A leaker who has been reliable in the past regarding Resident Evil may have revealed the release date of Resident Evil Village.